UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Sumanta Kumar Pal, MD
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Daniel George, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Reference Centers
    • Urinary Catheters
      • Indwelling Catheters
      • Intermittent Catheters
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO 2019
        • ASCO GU 2019
        • ESMO 2018
        • ESMO 2019
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA 2018
        • PCF 2018
        • PCF 2019
        • SNMMI Curriculum
    • Urologic Oncology
      • Bladder Cancer
        • Bladder Cancer
        • Advanced Bladder Cancer
        • Bladder Cancer Special Session EAU 2019
      • Kidney Cancer
        • Advanced Kidney Cancer
        • Renal Cancer
      • Prostate Cancer
        • Active Surveillance: Prostate Cancer
        • Advanced Prostate Cancer
        • CRPC with Bone Metastases
        • Imaging: Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Upper Tract Urothelial Tumors
        • Upper Tract Urothelial Carcinoma
    • Pelvic Health & Reconstruction
      • Bladder Health
      • Indwelling Catheters
      • Intermittent Catheters
      • Nocturia & Lower Urinary Tract Conditions
    • Endourology
      • Endourology Today
      • Endourology
  • Journals
      Print publications focusing on urological cancer treatments through original commentary & articles
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 Biennial Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2019 Annual Meeting
      • 2019 ASCO GU Symposium
      • 2018 Annual Meeting
      • 2018 ASCO GU Symposium
      • 2017 Annual Meeting
    • American Urological Association (AUA)
      • 2019 Annual Meeting
      • 2018 Northeastern Section
      • 2018 Annual Meeting
      • 2017 Quality Improvement Summit
      • 2017 Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2019 Think Tank
    • Canadian Urological Association (CUA)
      • 2019 CUOS Summit
      • 2018 Annual Meeting
      • 2017 Annual Meeting
    • Clinical Conference
      • 2019 American College of Surgeons
      • 2018 American College of Surgeons
    • European Association of Urology (EAU)
      • 2019 Annual Congress
      • ESOU 2019
      • 2018 Annual Congress
      • ERUS 2018
      • ESOU 2018
      • PCa 2018
    • Enhanced Recovery After Surgery (ERAS)
      • 2019 ERAS Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2019 Annual Congress
      • 2018 Annual Congress
      • 2017 Annual Congress
    • International Bladder Cancer Network (IBCN)
      • 2019 Meeting
      • 2018 Meeting
    • International Continence Society (ICS)
      • 2018 Meeting
    • Mexican Association of Oncological Urology
      • 2018 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2019 Annual Congress
      • 2018 Annual Congress
      • 2017 Annual Congress
    • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
      • 2019 Therapeutics Conference
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2019 Congress
      • 2018 Congress
    • Society of Urologic Oncology (SUO)
      • 2019 Annual Meeting
      • 2018 Annual Meeting
      • 2017 Annual Meeting
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
      • 2017 Symposium
    • World Congress of Endourology and SWL (WCE)
      • 2019 Annual Meeting
      • 2018 Annual Meeting
      • 2017 Annual Meeting
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
  • Calendar
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer
  5. Conferences

GU Cancers Symposium 2014

Recent Abstracts
Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer - Abstract April 24, 2014
GU Cancers Symposium 2014 - Axitinib: Common questions related to real-world use of a new treatment option in advanced renal cell carcinoma - Poster February 5, 2014
GU Cancers Symposium 2014 - Heterogeneity of intermediate prognosis patients with metastatic renal cell cancer treated with sunitinib - Poster February 5, 2014
GU Cancers Symposium 2014 - Impact of angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database - Poster February 5, 2014
GU Cancers Symposium 2014 - Correlation between patient-reported fatigue and hemoglobin levels in metastatic renal cell carcinoma patients receiving sunitinib - Poster February 5, 2014
GU Cancers Symposium 2014 - Growth kinetics and outcomes of clinical T1b renal masses under active surveillance - Poster February 5, 2014
GU Cancers Symposium 2014 - Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma - Poster February 5, 2014
GU Cancers Symposium 2014 - Open-label, phase II RAPTOR study of everolimus for papillary mRCC: Efficacy in type 1 and type 2 histology - Poster February 5, 2014
GU Cancers Symposium 2014 - In vitro and in vivo effects of the mTOR inhibitors everolimus and temsirolimus - Poster February 5, 2014
GU Cancers Symposium 2014 - Everolimus as second-line therapy for metastatic renal cell carcinoma after one previous VEGF-targeted therapy: Final results of the noninterventional change study - Poster February 5, 2014
GU Cancers Symposium 2014 - Biomarker analysis from a phase III trial (GOLD) of dovitinib vs sorafenibin patients with metastatic renal cell carcinoma after one prior VEGF pathway-targeted therapy and one prior mTOR inhibitor therapy - Poster February 5, 2014
GU Cancers Symposium 2014 - Second-line prescribing preferences of U.S.-based medical oncologists following first-line TKI in patients with metastatic clear cell renal cell carcinoma - Poster February 4, 2014
GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Poster February 4, 2014
GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Poster February 4, 2014
GU Cancers Symposium 2014 - Consideration of height-based rather than weight-based dosing as a more appropriate method of treating with radium-223 - Poster February 4, 2014
GU Cancers Symposium 2014 - Clinical and biologic factors for immune response to sipuleucel-T for metastatic castrate-resistant prostate cancer - Poster February 4, 2014
GU Cancers Symposium 2014 - Increase in bone scan index during abiraterone treatment in relation to reduced survival in mCRPC patients - Poster February 4, 2014
GU Cancers Symposium 2014 - Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7 - Poster February 4, 2014
GU Cancers Symposium 2014 - The effect of cell cycle progression score on treatment decisions in prostate cancer: Results of an ongoing registry trial - Poster February 4, 2014
GU Cancers Symposium 2014 - Cell cycle progression score to predict metastatic progression of clear cell renal cell carcinoma after resection - Poster February 4, 2014
Page 1 of 6
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
  • End
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2019 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free